In contrast, other investigations have demonstrated that lactate‐induced histone lactylation in glioblastoma enhances immunosuppressive activity and that blocking PERK‐driven lactylation may improve immunotherapy outcomes. The gene discussed is EIF2AK3; the disease is glioblastoma.